Exosomes derived from miR-26a-modified MSCs promote axonal regeneration via the PTEN/AKT/mTOR pathway following spinal cord injury
Open accessThe DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
Background: Exosomes derived from the bone marrow mesenchymal stem cell (MSC) have shown great potential in spinal cord injury (SCI) treatment. This research was designed to investigate the therapeutic effects of miR-26a-modified MSC-derived exosomes (Exos-26a) following SCI. Methods: Bioinformatics and data mining were performed to explore the role of miR-26a in SCI. Exosomes were isolated from miR-26a-modified MSC culture medium by ultracentrifugation. A series of experiments, including assessment of Basso, Beattie and Bresnahan scale, histological evaluation, motor-evoked potential recording, diffusion tensor imaging, and western blotting, were performed to determine the therapeutic influence and the underlying molecular mechanisms of Exos-26a in SCI rats. Results: Exos-26a was shown to promote axonal regeneration. Furthermore, we found that exosomes derived from miR-26a-modified MSC could improve neurogenesis and attenuate glial scarring through PTEN/AKT/mTOR signaling cascades. Conclusions: Exosomes derived from miR-26a-modified MSC could activate the PTEN-AKT-mTOR pathway to promote axonal regeneration and neurogenesis and attenuate glia scarring in SCI and thus present great potential for SCI treatment. Graphical abstract:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A growing number of studies suggest EVs derived from various cell lines, such as NSCs and MSC are neuroprotective, angiogenic, and immunomodulatory.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [292]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Spontaneous Human Adult Stem Cell Transformation
Rubio, D., Garcia-Castro, J., Martín, M. C., de la Fuente, R., Cigudosa, J. C., Lloyd, A. C., & Bernad, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4194 · Cited by 1,036
RetractedHou, K., Li, G., Zhao, J., Xu, B., Zhang, Y., Yu, J., & Xu, K. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1725-8 · Cited by 97
RetractedEffect of miR-26a on diabetic rats with myocardial injury by targeting PTEN.
Cai, S.-S., Tao, X.-W., Long, Y., Xia, K., & Zhang, Y. (2019) · PubMed · doi:10.26355/eurrev_201908_18661 · Cited by 13
RetractedValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Shedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Ahuja, C. S., Wilson, J. R., Nori, S., Kotter, M. R. N., Druschel, C., Curt, A., & Fehlings, M. G. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.18 · Cited by 2,441
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S. K., Choo, A., Chen, T. S., Salto-Tellez, M., Timmers, L., Lee, C. N., El Oakley, R. M., et al. (2010) · Stem Cell Research · doi:10.1016/j.scr.2009.12.003 · Cited by 2,215 · cited 1×
“To date, MSC exosomes have been reported to promote spinal cord injury recovery [27], improve graft-versus-host disease (GVHD) [28], reduce pulmonary hypertension [29], promote hepatic recovery [30], reduce myocardial ischemia/refusion injury [31], inhibit limb ischemia [32], and ameliorate wound healing [33].”
BackgroundHaematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium
Balsam, L. B., Wagers, A. J., Christensen, J. L., Kofidis, T., Weissman, I. L., & Robbins, R. C. (2004) · Nature · doi:10.1038/nature02460 · Cited by 1,736
Abels, E. R., & Breakefield, X. O. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0366-z · Cited by 1,678 · cited 1×
“formed by endocytosis and the inward germination of the cell membrane, with extracellular components and cell surface proteins [21].”
Background
Research works printed but not linked: 3
- Xu J, Xiao Y, Liu B, Pan S, Liu Q, Shan Y, Li S, Qi Y, Huang Y, Jia L. Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via F UT4 enhanced fucosylation and PI3K/Akt pathway. J Exp Clin Cancer Res. 2020;39(1):54. https://doi.org/10.1186/s13046-020-01562-6. · DOI
- Liu W, Rong Y, Wang J, Zhou Z, Ge X, Ji C, Jiang D, Gong F, Li L, Chen J, Zhao S, Kong F, Gu C, Fan J, Cai W. Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spin al cord injury by shifting microglial M1/M2 polarization. J Neuroinflammation. 2020;17(1):47. https://doi.org/10.1186/s12974-020-1726-7. · DOI · Paper page
- Jiang JJ, Liu CM, Zhang BY, Wang XW, Zhang M, Zhang SR, Hall P, Hu YW, Zhou FQ. MicroRNA-26a supports mammalian axon regeneration in vivo by suppressing GSK3¦Â expression. Cell Death Dis. 2015;6(8):e1865. https://doi.org/10.1038/cddis.2015.239. · DOI · Paper page
Cited by
Kou, M., Huang, L., Yang, J., Chiang, Z., Chen, S., Liu, J., Guo, L., Zhang, X., Zhou, X., Xu, X., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05034-x · Cited by 640
Hua, T., Yang, M., Song, H., Kong, E., Deng, M., Li, Y., Li, J., Liu, Z., Fu, H., Wang, Y., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01522-6 · Cited by 189
“Exosomes protect SCI from glia scarring and axonal injury by transferring miR-26a to the spinal cord [35].”
BackgroundVerma, N., & Arora, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17080990 · Cited by 173
“Complementary policy efforts should also focus on incentivizing research and development in EV technology through targeted grants and funding, thereby empowering emerging scientists and organizations to contribute meaningfully to this field [111,112].”
Chen, S., Sun, F., Qian, H., Xu, W., & Jiang, J. (2022) · Stem Cells International · doi:10.1155/2022/1779346 · Cited by 142
“In addition, MSC-exosomes modified by miR-126 and miR-26a protect neurons in rats with spinal cord injury, stimulate axon regeneration, and improve the recovery of limb motor function after spinal cord injury [128, 129].”
BackgroundEmerging Exosomes and Exosomal MiRNAs in Spinal Cord Injury
Feng, J., Zhang, Y., Zhu, Z., Gu, C., Waqas, A., & Chen, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703989 · Cited by 106
Metadata
- Authors
- Chen, Y., Tian, Z., He, L., Liu, C., Wang, N., Rong, L., & Liu, B.
- Affiliations
- Sun Yat-sen University (CN)
- Corresponding author
- Rong, Limin
- Liu, Bin
- Venue
- Stem Cell Research & Therapy
- Published
- 2021-04-05
- Volume
- 12
- Issue
- 1
- Pages
- 224-224
- ISSN
- 1757-6512 (ISSN-L)
- PMC
- PMC8022427
- OpenAlex
- W3144305753
- Cited by
- 106
- References
- 93
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 23 · 2023: 22 · 2022: 19 · 2021: 3
- FWCI
- 11.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Stem Cell Research & Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- The National Key Research and Development Program of China (2017YFA0105400)
- The Key Research and Development Program of Guangdong Province (20180236)
- The Clinical Innovation Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR0201006)
- National Natural Science Foundation of China (81772349, 81772398, 81472122)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- spinal cord injury, exosomes, mesenchymal stem cells, miR-26a, axon regeneration, neurogenesis, glial scar, bone marrow mesenchymal stem cells, exosome therapy
- MeSH terms
- Animals, Spinal Cord, Spinal Cord Injuries, MicroRNAs, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, Rats, Exosomes, Diffusion Tensor Imaging, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exosomes derived from miR-26a-modified MSCs promote axonal regeneration via the PTEN/AKT/mTOR pathway following spinal cord injury. https://app.cochat.ai/papers/10.1186/s13287-021-02282-0
- The paper
- Chen, Y., Tian, Z., He, L., Liu, C., Wang, N., Rong, L., & Liu, B. (2021). Exosomes derived from miR-26a-modified MSCs promote axonal regeneration via the PTEN/AKT/mTOR pathway following spinal cord injury. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-021-02282-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.